Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02156258 · ClinicalTrials.gov registry record

Acquisition of Breast Mammography Images

A clinical trial of Breast Cancer, sponsored by Fujifilm Medical Systems USA.

Completed
Registry status
1,232
Enrollment target
5
Study locations

NCT02156258: Completed study of Breast Cancer, sponsored by Fujifilm Medical Systems USA.

NCT02156258 is a study of Breast Cancer that has completed, run by Fujifilm Medical Systems USA. The registered enrollment target is 1,232 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02156258, a study of Breast Cancer, has completed, sponsored by Fujifilm Medical Systems USA.

COMPLETED
Registry status
1,232 participants
Enrollment target
5
Study locations

Study Summary

This is a case collection study of breast images using standard and new mammography technology.

Conditions Studied

Interventions

  • DEVICE FFDM Mammography
  • DEVICE DBT Mammography

Study Locations (5)

Arizona

  • Scottsdale Medical Imaging, Ltd - Scottsdale

Iowa

  • University of Iowa Hospitals & Clinics - Iowa City

New York

  • Elizabeth Wende Breast Care, LLC - Rochester

North Carolina

  • University of North Carolina - at Chapel Hill - Chapel Hill

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 1,232 participants
Start Date 2014-06
Est. Completion 2017-01

Sponsor

Fujifilm Medical Systems USA

13 total trials

What the Registry Record Tells You About NCT02156258

The ClinicalTrials.gov registry entry for NCT02156258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (56% lower). The listed sponsor is Fujifilm Medical Systems USA, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which FFDM Mammography is the first listed.

NCT02156258 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Iowa, New York.

Frequently Asked Questions

What is clinical trial NCT02156258 about?

NCT02156258 is a clinical study titled "Acquisition of Breast Mammography Images". This is a case collection study of breast images using standard and new mammography technology.

What is the current status of trial NCT02156258?

This trial is currently completed. The enrollment target is 1,232 participants. The study started on 2014-06. Estimated completion is 2017-01.

What conditions does trial NCT02156258 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02156258?

The interventions under investigation include: FFDM Mammography (DEVICE), DBT Mammography (DEVICE).

Who is sponsoring clinical trial NCT02156258?

This trial is sponsored by Fujifilm Medical Systems USA, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02156258 being conducted?

This trial has 5 study locations across Arizona, Iowa, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.